Literature DB >> 21719755

Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study.

Daniela J Lamas1, Steven M Kawut, Emilia Bagiella, Nisha Philip, Selim M Arcasoy, David J Lederer.   

Abstract

RATIONALE: Idiopathic pulmonary fibrosis is often initially misdiagnosed. Delays in accessing subspecialty care could lead to worse outcomes among those with idiopathic pulmonary fibrosis.
OBJECTIVES: To examine the association between delayed access to subspecialty care and survival time in idiopathic pulmonary fibrosis.
METHODS: We performed a prospective cohort study of 129 adults who met American Thoracic Society criteria for idiopathic pulmonary fibrosis evaluated at a tertiary care center. Delay was defined as the time from the onset of dyspnea to the date of initial evaluation at a tertiary care center. We used competing risk survival methods to examine survival time and time to transplantation.
MEASUREMENTS AND MAIN RESULTS: The mean age was 63 years and 76% were men. The median delay was 2.2 years (interquartile range 1.0–3.8 yr), and the median follow-up time was 1.1 years. Age and lung function at the time of evaluation did not vary by delay. A longer delay was associated with an increased risk of death independent of age, sex, forced vital capacity, third-party payer, and educational attainment (adjusted hazard ratio per doubling of delay was 1.3, 95% confidence interval 1.03 to 1.6). Longer delay was not associated with a lower likelihood of undergoing lung transplantation.
CONCLUSIONS: Delayed access to a tertiary care center is associated with a higher mortality rate in idiopathic pulmonary fibrosis independent of disease severity. Early referral to a specialty center should be considered for those with known or suspected interstitial lung disease.

Entities:  

Mesh:

Year:  2011        PMID: 21719755      PMCID: PMC3208648          DOI: 10.1164/rccm.201104-0668OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

1.  Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Talmadge E King; Becki Bucher Bartelson; Jason S Vourlekis; Marvin I Schwarz; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

2.  Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis.

Authors:  D J Lederer; S M Arcasoy; R G Barr; J S Wilt; E Bagiella; F D'Ovidio; J R Sonett; S M Kawut
Journal:  Am J Transplant       Date:  2006-07-26       Impact factor: 8.086

3.  Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis.

Authors:  D J Lederer; C E Caplan-Shaw; M K O'Shea; J S Wilt; R C Basner; M N Bartels; J R Sonett; S M Arcasoy; S M Kawut
Journal:  Am J Transplant       Date:  2006-02       Impact factor: 8.086

4.  Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?

Authors:  Kevin R Flaherty; Adin-Cristian Andrei; Talmadge E King; Ganesh Raghu; Thomas V Colby; Athol Wells; Nadir Bassily; Kevin Brown; Roland du Bois; Andrew Flint; Steven E Gay; Barry H Gross; Ella A Kazerooni; Robert Knapp; Edmund Louvar; David Lynch; Andrew G Nicholson; John Quick; Victor J Thannickal; William D Travis; James Vyskocil; Frazer A Wadenstorer; Jeffrey Wilt; Galen B Toews; Susan Murray; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

5.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.

Authors:  David J Lederer; Paul L Enright; Steven M Kawut; Eric A Hoffman; Gary Hunninghake; Edwin J R van Beek; John H M Austin; Rui Jiang; Gina S Lovasi; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2009-06-19       Impact factor: 21.405

6.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.

Authors:  J D Hosenpud; L E Bennett; B M Keck; E B Edwards; R J Novick
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

7.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

Authors:  T E King; J A Tooze; M I Schwarz; K R Brown; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

Review 8.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

9.  Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

Authors:  Panagiota I Latsi; Roland M du Bois; Andrew G Nicholson; Thomas V Colby; Danai Bisirtzoglou; Ageliki Nikolakopoulou; Srihari Veeraraghavan; David M Hansell; Athol U Wells
Journal:  Am J Respir Crit Care Med       Date:  2003-06-05       Impact factor: 21.405

10.  MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Ivan O Rosas; Thomas J Richards; Kazuhisa Konishi; Yingze Zhang; Kevin Gibson; Anna E Lokshin; Kathleen O Lindell; Jose Cisneros; Sandra D Macdonald; Annie Pardo; Frank Sciurba; James Dauber; Moises Selman; Bernadette R Gochuico; Naftali Kaminski
Journal:  PLoS Med       Date:  2008-04-29       Impact factor: 11.069

View more
  62 in total

Review 1.  Update in diffuse parenchymal lung disease 2011.

Authors:  Tracy R Luckhardt; Joachim Müller-Quernheim; Victor J Thannickal
Journal:  Am J Respir Crit Care Med       Date:  2012-07-01       Impact factor: 21.405

Review 2.  Cardiovascular implications of idiopathic pulmonary fibrosis: A way forward together?

Authors:  Christopher L Mosher; Robert J Mentz
Journal:  Am Heart J       Date:  2020-05-06       Impact factor: 4.749

Review 3.  Selecting lung transplant candidates: where do current guidelines fall short?

Authors:  Jaime L Hook; David J Lederer
Journal:  Expert Rev Respir Med       Date:  2012-02       Impact factor: 3.772

4.  Idiopathic Pulmonary Fibrosis: A Study of 46 Patients from Western India: Clinical Presentations and Survival.

Authors:  Subramanian Natarajan; Poonam Subramanian
Journal:  Turk Thorac J       Date:  2015-07-01

5.  [Chronic fibrosing lung diseases : Idiopathic pulmonary fibrosis from the perspective of its differential diagnosis].

Authors:  R C Dartsch; L Fink; A Breithecker; P Markart; S Tello; W Seeger; A Günther
Journal:  Internist (Berl)       Date:  2019-04       Impact factor: 0.743

6.  Palliative care and location of death in decedents with idiopathic pulmonary fibrosis.

Authors:  Kathleen O Lindell; Zhan Liang; Leslie A Hoffman; Margaret Q Rosenzweig; Melissa I Saul; Joseph M Pilewski; Kevin F Gibson; Naftali Kaminski
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

7.  The palliative care needs of patients with idiopathic pulmonary fibrosis: A qualitative study of patients and family caregivers.

Authors:  Kathleen Oare Lindell; Dio Kavalieratos; Kevin F Gibson; Laura Tycon; Margaret Rosenzweig
Journal:  Heart Lung       Date:  2016-11-18       Impact factor: 2.210

8.  Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.

Authors:  Justin M Oldham; Ayodeji Adegunsoye; Satinderpal Khera; Elyse Lafond; Imre Noth; Mary E Strek; Michael Kadoch; Jonathan H Chung
Journal:  Ann Am Thorac Soc       Date:  2018-06

9.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 10.  Idiopathic pulmonary fibrosis: early detection and referral.

Authors:  Justin M Oldham; Imre Noth
Journal:  Respir Med       Date:  2014-04-04       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.